Can circulating tumour DNA guide treatment intensification in de novo metastatic prostate cancer?
What’s new in advanced and metastatic prostate cancer treatment | BCH Lecture Sept 23
Bone Metastasis: Diagnosis and Scans | #MarkScholzMD #AlexScholz #PCRI
Case discussion on which is the best combination treatment for de novo mHSPC
Case 2: High-Volume Versus Low-Volume Metastatic CSPC
Novel Treatment Strategies and Latest Evidence for Metastatic Castration-Sensitive Prostate Cancer
What Are Advanced Prostate Cancer Treatment Options?
The evolving standard of care for patients with metastatic hormone-sensitive prostate cancer
Treatment advances in metastatic prostate cancer - Dr. Edmond Kwan
Oligo-metastatic Prostate Cancer
Radiotherapy in Oligometastatic PCa and Treating the Primary in De Novo Oligometastatic PCa
Updates on Management of Metastatic Hormone-Sensitive Prostate Cancer
Metastasis-Directed Therapy: Radiation Oncology Updates and Perspective
ADT Resistant Metastatic Prostate Cancer (mCRPC) - 2021 Prostate Cancer Patient Conference
Is There Still a Role for Docetaxel in mHSPC?
PSMA-PET for patients with high-risk for de novo N1 disease
New Concepts in Prostate Cancer Care: What Oncologists Need to Know to Optimize Patient Outcomes
Metastatic hormone sensitive prostate cancer
Practice-changing data from ESMO 2021 in prostate cancer
Diagnosing Bone Mets in Prostate Cancer